Last $76.28 USD
Change Today +0.34 / 0.45%
Volume 150.2K
DVA On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 10:36 AM 12/22/14 All times are local (Market data is delayed by at least 15 minutes).

davita healthcare partners i (DVA) Snapshot

Open
$76.00
Previous Close
$75.94
Day High
$76.53
Day Low
$75.99
52 Week High
10/31/14 - $78.52
52 Week Low
02/4/14 - $62.52
Market Cap
16.4B
Average Volume 10 Days
1.1M
EPS TTM
$3.72
Shares Outstanding
214.9M
EX-Date
--
P/E TM
20.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for DAVITA HEALTHCARE PARTNERS I (DVA)

davita healthcare partners i (DVA) Related Businessweek News

View More BusinessWeek News

davita healthcare partners i (DVA) Details

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease. It operates kidney dialysis centers and provides related lab services primarily in outpatient dialysis centers and in contracted hospitals. The company offers outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers DaVita Rx, a pharmacy that provides oral medications to patients with ESRD; disease management services; vascular access services; ESRD clinical research programs; physician services; and direct primary care services. As of March 31, 2014, it operated 2,173 outpatient dialysis centers, including 2,098 centers located in the United States; and 75 centers located in 10 countries outside the United States. The company was formerly known as DaVita Inc. and changed its name to DaVita HealthCare Partners Inc. in November 2012. DaVita HealthCare Partners Inc. was founded in 1994 and is headquartered in Denver, Colorado.

57,400 Employees
Last Reported Date: 02/21/14
Founded in 1994

davita healthcare partners i (DVA) Top Compensated Officers

Co-Chairman, Chief Executive Officer and Chie...
Total Annual Compensation: $1.1M
Chief Financial Officer
Total Annual Compensation: $213.6K
Chief Executive Officer of Kidney Care Divisi...
Total Annual Compensation: $765.4K
Chief Accounting Officer
Total Annual Compensation: $650.0K
Chief Legal Officer
Total Annual Compensation: $650.0K
Compensation as of Fiscal Year 2013.

davita healthcare partners i (DVA) Key Developments

DaVita HealthCare Partners Inc.(NYSE:DVA) dropped from S&P 500 Value Index

DaVita HealthCare Partners Inc.(NYSE:DVA) dropped from S&P 500 Value Index

DaVita Healthcare Partners Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Updates Consolidated Earnings Guidance for the Year 2014; Provides Earnings Guidance for the Year 2015

DaVita HealthCare Partners Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported total net revenue of $3,251,824,000 against $2,999,586,000 a year ago. Operating income was $437,536,000 against $377,074,000 a year ago. Income from continuing operations before income taxes was $336,412,000 against $270,766,000 a year ago. Income from continuing operations was $219,784,000 or $0.85 diluted per share against $169,836,000 or $0.64 diluted per share a year ago. Net income attributable to the company was $184,122,000 or $0.85 diluted per share against $136,628,000 or $0.64 diluted per share a year ago. Adjusted operating income was $454,536,000 against $481,795,000 a year ago. The company continued to generate strong cash flows as operating cash flow was $848 million in the third quarter. This was unusually high due to: one, the timing of cash tax payments; and two, the timing of years working capital items, in particular a reduction in accounts receivable DSO. For the nine months, the company reported total net revenue of $9,467,089,000 against $8,700,841,000 a year ago. Operating income was $1,363,056,000 against $1,065,955,000 a year ago. Income from continuing operations before income taxes was $955,308,000 against $744,958,000 a year ago. Income from continuing operations was $612,942,000 or $2.38 diluted per share against $499,692,000 or $1.96 diluted per share a year ago. Net income attributable to the company was $515,094,000 or $2.38 diluted per share against $421,168,000 or $1.96 diluted per share a year ago. Net cash provided by operating activities was $1,529,398,000 against $1,419,154,000 a year ago. Additions of property and equipment, net were $443,507,000 against $399,527,000 a year ago. Purchase of intangible assets was $50,000 against $53,000 a year ago. Adjusted operating income was $1,380,056,000 against $1,413,699,000 a year ago. The company updated consolidated operating income guidance for 2014 to now be in the range of $1.785 billion to $1.835 billion. The company's previous consolidated operating income guidance for 2014 was in the range of $1.755 billion to $1.840 billion. The company updated consolidated operating cash flow guidance for 2014 to now be in the range of $1.700 billion to $1.800 billion. The company's previous consolidated operating cash flow guidance for 2014 was in the range of $1.450 billion to $1.550 billion. The company now expects the full year effective tax rate for 2014 to be in the range of 39.5% to 40%. The company expects consolidated operating income for 2015 to be in the range of $1.750 billion to $1.900 billion. The company expects consolidated operating cash flow for 2015 to be in the range of $1.500 billion to $1.700 billion.

Centura Health and DaVita HealthCare Partners Inc. Form New Joint Venture in Colorado and Kansas

Centura Health and DaVita HealthCare Partners Inc. announced a new joint venture that will offer a differentiated health care delivery model to help optimize health care value and lower costs for consumers in Colorado and Kansas. The two partners will combine their expertise to provide enhanced resources that increase coordination of care, equip care providers with sophisticated analytical tools and focus on prevention. The new entity will be based in Colorado and jointly owned 50/50 by Englewood-based Centura Health and Denver-based DaVita HealthCare Partners. Together, Centura Health and DaVita HealthCare Partners will arm primary care providers, specialists and Centura Health acute and ambulatory care facilities with a range of services and tools. These include care coordination, disease management, risk stratification, consumer engagement and more. This new health care model can lessen the complexity, confusion and fragmentation of health care for consumers by helping care providers to be more effective in making critical decisions about consumer care, reducing unnecessary and costly medical interventions and rewarding providers for helping consumers actively manage and maintain their health. The new joint venture combines the expertise of the region's leading health care system and a nationally recognized leader in physician-centric coordinated care. It will be used to power Colorado Health Neighborhoods (CHN), Centura Health's physician-led network of providers.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DVA:US $76.28 USD +0.34

DVA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Apollo Medical Holdings Inc $0.42 USD 0.00
Fresenius Medical Care AG & Co KGaA €61.34 EUR +0.74
Fresenius SE & Co KGaA €43.43 EUR +0.82
IPC The Hospitalist Co Inc $46.41 USD +0.375
Team Health Holdings Inc $58.85 USD +0.43
View Industry Companies
 

Industry Analysis

DVA

Industry Average

Valuation DVA Industry Range
Price/Earnings 22.6x
Price/Sales 1.3x
Price/Book 3.3x
Price/Cash Flow 12.5x
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DAVITA HEALTHCARE PARTNERS I, please visit www.davita.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.